A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Clinical trial NCT01286753 · COMPLETED
Trial details
- NCT number
- NCT01286753
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-11-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.